CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic Cancer

Célia Jacoberger-Foissac(Institute for Research in Immunology and Cancer), John Stagg(Institute for Research in Immunology and Cancer)
Cancer Immunology Research
November 21, 2022
Cited by 71


Related Papers

Anti‐CD73 therapy impairs tumor angiogenesis
|International Journal of Cancer|2013|170
The CD73 immune checkpoint promotes tumor cell metabolic fitness
|bioRxiv (Cold Spring Harbor Laboratory)|2022|2